Dennis B. Ph D. Gillings

Dennis B. Ph D. Gillings is a declared insider at 2 companies; the most frequent names are Iqvia Holdings Inc. and Icagen, Inc. In total, 24 filings cover trades dated from 7 June 2006 to 28 August 2017.

In open-market terms, that means 2 purchases worth €794k on one side and 11 sales worth €661.0M on the other. Sales outweigh purchases by €660.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 1 option exercise. In 2017 alone, the filings show no purchases and 3 sales.

On 30 August 2017 came the latest disclosure, an open-market sale for €3.1M in Iqvia Holdings Inc. The last purchase on record was published on 8 February 2007, which is 7,214 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.